Financial Performance - Total revenue for the year ended December 31, 2024, was HKD 53,010,000, an increase of 8.9% compared to HKD 48,831,000 in 2023[4] - Gross profit for the same period was HKD 31,698,000, up from HKD 28,828,000, reflecting a gross margin improvement[4] - The net profit for the year was HKD 2,871,000, a significant recovery from a net loss of HKD 8,791,000 in 2023[4] - The company reported a basic and diluted loss per share of HKD 0.12, improved from HKD 1.61 in the previous year[4] - Total operating profit for the company reached HKD 11,191,000 in 2024, a turnaround from a loss of HKD 613,000 in 2023[22] - The group reported a net profit of approximately HKD 2,871,000 for the year, compared to a loss of HKD 8,791,000 in 2023[56] Revenue Breakdown - The group's revenue for the year ending December 31, 2024, reached HKD 53,010,000, with healthcare and medical services contributing HKD 39,705,000 and beauty and fitness services contributing HKD 13,305,000[19] - For the year ending December 31, 2023, the group's revenue was HKD 48,831,000, with healthcare and medical services at HKD 31,212,000 and beauty and fitness services at HKD 17,619,000, indicating a year-over-year growth in total revenue of approximately 8.9%[19] - Total revenue for the healthcare and medical business was HKD 39,705,000 in 2024, up from HKD 31,212,000 in 2023, reflecting a growth of 27.9%[29] - Total revenue for the beauty and fitness business decreased to HKD 13,305,000 in 2024 from HKD 17,619,000 in 2023, a decline of 24.5%[29] Assets and Liabilities - Total assets decreased to HKD 113,445,000 from HKD 136,201,000, indicating a reduction in overall asset base[6] - Total liabilities were reduced to HKD 67,766,000 from HKD 92,589,000, showing a decrease in financial obligations[7] - As of December 31, 2024, the group has total assets of approximately HKD 113,445,000 and total liabilities of approximately HKD 25,108,000, resulting in a leverage ratio of about 22.13%[62] - The current ratio as of December 31, 2024, is approximately 1.30, compared to 1.24 as of December 31, 2023[62] Operational Highlights - The company plans to focus on market expansion and new product development in the upcoming fiscal year[3] - The management highlighted ongoing efforts in technology research and development to enhance competitive positioning[3] - The healthcare and medical segment operates blood dialysis centers and hospitals, while the beauty and fitness segment focuses on the sale of beauty and fitness products and related services[20] - The healthcare and medical services segment continues to operate hospitals in Hunan Province, China, optimizing supply chain procurement and increasing the use of domestic medical supplies[45] Expenses and Costs - Direct costs and operating expenses amounted to approximately HKD 21,312,000, reflecting an increase of about 6.54% from HKD 20,003,000 in 2023[49] - Selling expenses decreased to approximately HKD 11,403,000, down about 14.07% from HKD 13,270,000 in 2023 due to cost control measures[51] - Administrative expenses increased to approximately HKD 23,471,000, up about 6.74% from HKD 21,989,000 in 2023, primarily due to increased depreciation costs after the relocation of a hospital[52] - Employee benefit expenses increased to HKD 24,365,000 in 2024 from HKD 22,728,000 in 2023, marking an increase of about 7.2%[32] - Financing costs decreased to HKD 1,688,000 in 2024 from HKD 2,278,000 in 2023, a reduction of 26%[31] Corporate Governance and Compliance - The financial statements are prepared in accordance with the Hong Kong Financial Reporting Standards, ensuring compliance with local accounting regulations[11] - The group has adopted several revised Hong Kong Financial Reporting Standards effective from January 1, 2024, which do not have a significant impact on the current and prior financial positions[13] - The company confirmed compliance with the Corporate Governance Code, except for the absence of an internal audit function due to operational scale[81] - An external consultant has been hired to establish an internal audit function and assist in reviewing the adequacy and effectiveness of the risk management and internal control systems[82] - The audit committee consists of three independent non-executive directors, with Mr. Cai Davi serving as the chairman, ensuring compliance with applicable accounting standards[85] Shareholder Information - The company did not declare any dividends for the year ending December 31, 2024, consistent with the previous year[37] - The company has maintained a weighted average number of ordinary shares issued at 659,894,693 for both 2024 and 2023, indicating stability in share capital[43] - The board does not recommend the payment of any dividends for the year[76] Employee and Operational Changes - The group employed 180 employees in Hong Kong and China as of December 31, 2024[77] - The group closed two loss-making beauty salons and reduced the scale of one salon in 2024 to cut costs[46] - The company did not buy, sell, or redeem any of its listed securities during the year[80] Miscellaneous - There are no significant ongoing or threatened litigations against the group as of the announcement date[78] - The company expresses gratitude to its directors, employees, shareholders, customers, suppliers, banks, and business partners for their support[88]
格林国际控股(02700) - 2024 - 年度业绩